Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
Abstract In this study, the minimal residual disease (MRD) levels in patients with multiple myeloma (MM) were assessed by comparing the new 8-color single-tube multiparameter flow cytometry method (DuraClone), which reduces the cost of antibodies and labor burden of laboratories, with the EuroFlow n...
Guardado en:
Autores principales: | Takeshi Yoroidaka, Kentaro Narita, Hiroyuki Takamatsu, Momoko Fujisawa, Shinji Nakao, Kosei Matsue |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0183caa16ebe49ea857003f9cf702b0b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria
por: Kentaro Narita, et al.
Publicado: (2021) -
Personalized immunoglobulin aptamers for detection of multiple myeloma minimal residual disease in serum
por: Claudia Tapia-Alveal, et al.
Publicado: (2020) -
Contabilidad en moneda dura
por: Carrasco P., Eduardo, et al.
Publicado: (1999) -
Surgical results of the resection of spinal meningioma with the inner layer of dura more than 10 years after surgery
por: Hiroyuki Tominaga, et al.
Publicado: (2021) -
La dura sopa de arroz
por: Liljana Arsovska, et al.
Publicado: (1996)